Cita APA

Wenger, K. J., Wagner, M., You, S., Franz, K., Harter, P. N., Burger, M. C., . . . Bähr, O. (2017). Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine. Oncol Lett.

Chicago Style Citation

Wenger, Katharina J., et al. "Bevacizumab As a Last-line Treatment for Glioblastoma Following Failure of Radiotherapy, Temozolomide and Lomustine." Oncol Lett 2017.

Cita MLA

Wenger, Katharina J., et al. "Bevacizumab As a Last-line Treatment for Glioblastoma Following Failure of Radiotherapy, Temozolomide and Lomustine." Oncol Lett 2017.